Skip to content

AngioDynamics ANGO Operating Cash Flow

Operating Cash Flow at other companies

Abbott logo
AbbottABT
$1.32B-7.2%
Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
$671M
TFX
TeleflexTFX
$46.66M+68.3%
Stryker logo
StrykerSYK
$581M+132%
Merit Medical Systems logo
Merit Medical SystemsMMSI
$40.68M+0.3%
ICU Medical logo
ICU MedicalICUI
$38.91M-24.2%

Other financials

Income statement

See full
Revenue$78.4M+8.9%
Gross profit$41.5M+6.7%
Operating income-$13.0M-29.8%
Net income-$8.1M-83.4%
EPS (diluted)-$0.19-72.7%

Balance sheet

See full
Cash & equivalents$37.8M-15.5%
Total debt$7.9M+10.2%
Total equity$173.4M-6.7%
Total assets$260.7M-8.7%

Cash flow

See full
CapEx$1.0M-43.5%
Free cash flow-$4.1M+72.4%

Valuation

See full
Market cap$564.42M+38.7%
Enterprise value$534.51M+48.0%
P/S1.8×+0.4×

Profitability

See full
Gross margin54.3%-0.1pp
Operating margin-11.3%-2.9pp
Net margin-10%-2.4pp
FCF margin5.5%

Returns & leverage

See full
Return on equity-17.5%-2.2pp
Debt / equity0.0×
Current ratio2.4×+0.1×

Where this comes from

Reported directly by AngioDynamics in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.

The official record: AngioDynamics’s 10-Q, filed April 2, 2026, on SEC EDGAR. View the filing →

Ask your AI about AngioDynamics's operating cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AngioDynamics's operating cash flow?
AngioDynamics (ANGO) reported operating cash flow of -$3.11M in Q4 2025.
How has AngioDynamics's operating cash flow changed year-over-year?
AngioDynamics's operating cash flow increased by 76.4% year-over-year, from -$13.16M to -$3.11M.
What does operating cash flow mean?
Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.